Treatment of Flag-IL-33Δ34-His expressing COPD cells resulted in a 2-fold increase in secreted IL-33Δ34 protein and a 10% increase in secretion efficiency, which could be reversed using the noncompetitive nSMase2 inhibitor GW4869 (Figure 3A). Here, SMPD3 is linked to chronic obstructive pulmonary disease.